Skip to main navigation
Fate Therapeutics, Inc.
  • About Us
    • Overview
    • Leadership
    • Corporate Responsibility
  • Pipeline
    • Overview
    • Product Candidates
      • FT819
      • FT825
      • FT836
      • FT839
      • FT522
    • Early/Expanded Access Policy
  • Science
    • Our Cells of Interest
    • iPSC Platform
    • Manufacturing
    • Publications & Presentations
  • Patients
    • Our Commitment
    • Our Therapy
    • Autoimmune Disease
    • Cancer
    • Clinical Trials
  • Collaborations
  • Careers and Culture
    • The Fate Way
    • Join Our Team
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financials & Filings
      • SEC Filings
      • Annual Reports and Proxies
    • Corporate Governance
    • Stock Information
      • Historical Stock Lookup
    • Investors FAQs
  • Contact
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financial & Filings
    • Corporate Governance
    • Stock Information
    • Investors FAQs

SEC Filing Details

Document Details

Form
10-Q
Filing Date
May 13, 2026
Document Date
Mar 31, 2026
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Fate Therapeutics, Inc.
Issuer
FATE THERAPEUTICS INC

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
XML - XBRL INSTANCE DOCUMENT

Shareholder Tools

Printed Materials
Email Alerts
Download Library
RSS News Feeds
Print Page
Share
Search

  • Facebook
  • LinkedIn
  • Twitter
  • RSS

© 2026 Fate Therapeutics | 12278 Scripps Summit Drive, San Diego, CA 92131 | 866.875.1833 | LEGAL

MENU
  • About Us
    • Overview
    • Leadership
    • Corporate Responsibility
  • Pipeline
    • Overview
    • Product Candidates
      • FT819
      • FT825
      • FT836
      • FT839
      • FT522
    • Early/Expanded Access Policy
  • Science
    • Our Cells of Interest
    • iPSC Platform
    • Manufacturing
    • Publications & Presentations
  • Patients
    • Our Commitment
    • Our Therapy
    • Autoimmune Disease
    • Cancer
    • Clinical Trials
  • Collaborations
  • Careers and Culture
    • The Fate Way
    • Join Our Team
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financials & Filings
      • SEC Filings
      • Annual Reports and Proxies
    • Corporate Governance
    • Stock Information
      • Historical Stock Lookup
    • Investors FAQs
  • Contact